Catapult Therapeutics
Company

Catapult Therapeutics

Biotechnology Research 'S-hertogenbosch, Noord-brabant, Nl 6 employees
Employees
6

Catapult Therapeutics Overview

Headquarters
'S-hertogenbosch, Noord-brabant, Nl
Industry
Biotechnology Research
Employees
6
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Catapult Therapeutics

Catapult Therapeutics is a privately held Dutch biotech company developing CAP-100 – an innovative first-in-class humanized anti-CCR7 antibody.

Compare Similar Companies to Catapult Therapeutics